News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
13 Results
Type
Article (4)
Press Release (9)
Section
Business (4)
Deals (5)
Drug Development (2)
News (8)
Tag
Alliances (1)
Clinical research (1)
Diagnostics (3)
IPO (3)
Mergers & acquisitions (2)
NextGen: Class of 2025 (1)
People (2)
Phase I (1)
Phase II (1)
Phase III (1)
Startups (1)
Date
2021 (1)
2018 (5)
2017 (4)
2016 (3)
13 Results for "cirina".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Decheng Leads $12 Million Series A In Diagnostics Newco Cirina
October 31, 2016
·
1 min read
Deals
Cancer Screening Tie-up: Hong Kong’s Cirina Merges With GRAIL, An Illumina Spin-Out
June 2, 2017
·
1 min read
Deals
Bay Area’s GRAIL Goes Global, Merges With Hong Kong’s Cirina to Focus on Cancer Detection
May 31, 2017
·
3 min read
Business
Helmed by Affymetrix (Santa Clara, California)-Illumina Alum, Bay Area Startup Cirina Emerges With $12 Million to Develop Noninvasive Tests for Early Cancer Screening
October 25, 2016
·
3 min read
Adela Debuts with $60M in Series A Financing and a Breakthrough Approach to Blood-Based Detection of Cancer and Other Diseases
Adela (formerly DNAMx) has launched with $60 million USD in Series A financing to enable the detection of cancer and other high-morbidity, high-mortality conditions through a blood test that harnesses the potential of the methylome
June 23, 2021
·
5 min read
Pharm Country
Hong Kong Test Shows Efficacy Of Early Cancer Liquid Biopsy Testing
August 10, 2017
·
1 min read
Business
Illumina and Loxo Oncology Join Forces to Develop Pan-Cancer Companion Diagnostics
Illumina is teaming up with Loxo Oncology to develop and commercialize a multi-gene panel for broad cancer profiling. It will seek approval for a version of Illumina’s TruSight Tumor 170 as a companion diagnostic for Loxo Oncology’s larotrectinib and LOXO-292.
April 10, 2018
·
3 min read
·
Mark Terry
Grail Raises $300 Million from China Investors for Early Cancer Diagnostics
Grail announced a $300 million C financing. Since early 2016, Grail has raised over $1.5 billion.
May 23, 2018
·
1 min read
Deals
Week In Review: Zai Lab Targets $1 Billion Valuation In Planned U.S. IPO
August 14, 2017
·
1 min read
Biotech Bay
GRAIL Grabs $300 Million Ahead of Possible IPO on Hong Kong Exchange
With a new chief executive officer on board, GRAIL, Inc. has secured a whopping $300 million in an oversubscribed Series C financing round led by multiple Chinese investment groups.
May 22, 2018
·
3 min read
·
Alex Keown
1 of 2
Next
